Quantum BioPharma Ltd. Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019
Quantum BioPharma Ltd. (QNTM) reported Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 of $5.25 per share for the 3-month period ending 2025-03-31, per its 6-K/A filed 2025-06-16.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 · last filed 2026-03-26
- Quantum BioPharma Ltd. weighted average exercise price of share options expired in share-based payment arrangement2019 for the quarter ending 2025-03-31 was $5.25, a 97.85% decline year-over-year.
- Quantum BioPharma Ltd. weighted average exercise price of share options expired in share-based payment arrangement2019 for the quarter ending 2024-03-31 was $243.75.
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 3 month | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 12 month |
|---|---|---|
| 2025-03-31 | $5.25 6-K/A · filed 2025-06-16 | |
| 2024-12-31 | $352.83 20-F · filed 2026-03-26 | |
| 2024-03-31 | $243.75 6-K/A · filed 2025-06-16 | |
| 2023-12-31 | $262.12 20-F · filed 2026-03-26 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 9 month |
|---|---|---|
| 2024-09-30 | 352.83 CAD/shares 6-K · filed 2025-11-06 | |
| 2024-06-30 | 352.95 CAD/shares 6-K · filed 2025-08-07 |